Home/News/Market context Source: Investing.com ↗ BTIG upgrades Orchestra BioMed stock rating on trial progress Published Sep 10, 2026 10:22 UTC | Translation unavailable. Please try again. Original report Read the original report on Investing.com ↗ Recommended marketsNo specific asset was identified in this report; browse live USDT reference pairs.Browse markets → USDC/USDT $1.00 -0.02% BTC/USDT $85,482.00 -0.67% ETH/USDT $2,718.96 -0.93% ZEC/USDT $1,621.10 +7.18% XRP/USDT $1.57 +2.10%